Evidence map›Paper›PMID 11526501›Full record

ArticleOncogene2001

E2F2 converts reversibly differentiated PC12 cells to an irreversible, neurotrophin-dependent state.

S P Persengiev, J Li, M L Poulin, D L Kilpatrick

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

S P PersengievDepartment of Cellular and Molecular Physiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.
J Li
M L Poulin
D L Kilpatrick
University of Massachusetts Chan Medical School · US

Funding

Transcriptional Control of Terminal DifferentiationR01CA079999 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI KILPATRICK, DANIEL L · 2001 to 2004
$1.1M
TRANSCRIPTIONAL CONTROL OF SPERMATOGENESISR01DK036468 · NIDDK · WORCESTER FOUNDATION FOR BIOMEDICAL RES · PI KILPATRICK, DANIEL L · 1986 to 2000
$345k
NCI NIH HHS CA-79999NIDDK NIH HHS DK36468
6 · The paper itself

Abstract

E2Fs play a central role in cell proliferation and growth arrest through their ability to regulate genes involved in cell cycle progression, arrest and apoptosis. Recent studies further indicate that this family of transcriptional regulators participate in cell fate/differentiation events. They are thus likely to have a prominent role in controlling the terminal differentiation process and its irreversibility. Here we have specifically examined the role of E2F2 in neuronal differentiation using a gain-of-function approach. Endogenous E2F2 increased in PC12 cells in response to nerve growth factor (NGF) and was also expressed in cerebellar granule neurons undergoing terminal differentiation. While PC12 cells normally undergo reversible dedifferentiation and cell cycle re-entry upon NGF removal, forced expression of E2F2 inhibited these events and induced apoptosis. Thus, E2F2 converted PC12-derived neurons from a reversible to a 'terminally' differentiated, NGF-dependent state, analogous to postmitotic sympathetic neurons. This contrasts with the effects of E2F4, which enhances the differentiation state of PC12 cells without affecting cell cycle parameters or survival. These results indicate that E2F2 may have a unique role in maintaining the postmitotic state of terminally differentiated neurons, and may participate in apoptosis in neurons attempting to re-enter the cell cycle. It may also be potentially useful in promoting the terminally arrested/differentiated state of tumor cells.

Indexed as

AnimalsApoptosisCell DifferentiationCell DivisionE2F2 Transcription FactorGene Expression RegulationNerve Growth FactorNerve Growth FactorsNeuronsPC12 CellsRatsTime FactorsTranscription FactorsTranscription, GeneticUp-RegulationE2F2 Transcription FactorNerve Growth FactorNerve Growth FactorsTranscription Factors

Identifiers

PMID11526501
OpenAlexW1990240568

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.